Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI114726

Identification of activated T cell receptor gamma delta lymphocytes in the liver of tumor-bearing hosts.

S Seki, T Abo, T Masuda, T Ohteki, A Kanno, K Takeda, H Rikiishi, H Nagura, and K Kumagai

Department of Microbiology, Tohoku University School of Dentistry, Sendai, Japan.

Find articles by Seki, S. in: PubMed | Google Scholar

Department of Microbiology, Tohoku University School of Dentistry, Sendai, Japan.

Find articles by Abo, T. in: PubMed | Google Scholar

Department of Microbiology, Tohoku University School of Dentistry, Sendai, Japan.

Find articles by Masuda, T. in: PubMed | Google Scholar

Department of Microbiology, Tohoku University School of Dentistry, Sendai, Japan.

Find articles by Ohteki, T. in: PubMed | Google Scholar

Department of Microbiology, Tohoku University School of Dentistry, Sendai, Japan.

Find articles by Kanno, A. in: PubMed | Google Scholar

Department of Microbiology, Tohoku University School of Dentistry, Sendai, Japan.

Find articles by Takeda, K. in: PubMed | Google Scholar

Department of Microbiology, Tohoku University School of Dentistry, Sendai, Japan.

Find articles by Rikiishi, H. in: PubMed | Google Scholar

Department of Microbiology, Tohoku University School of Dentistry, Sendai, Japan.

Find articles by Nagura, H. in: PubMed | Google Scholar

Department of Microbiology, Tohoku University School of Dentistry, Sendai, Japan.

Find articles by Kumagai, K. in: PubMed | Google Scholar

Published August 1, 1990 - More info

Published in Volume 86, Issue 2 on August 1, 1990
J Clin Invest. 1990;86(2):409–415. https://doi.org/10.1172/JCI114726.
© 1990 The American Society for Clinical Investigation
Published August 1, 1990 - Version history
View PDF
Abstract

T cell receptor (TcR)gamma delta cells are known to be a minor population of T lymphocytes in the blood (less than 10%) and other peripheral lymphoid organs in healthy donors. We demonstrated here that a large proportion of TcR gamma delta cells, i.e., up to 30% of mononuclear cells (MNC) were detectable in the liver, but not other lymphoid organs of cancer patients. More importantly, the majority of such TcR gamma delta cells (greater than 70%) were shown to be lymphoblastic by electron microscopy. An activation marker of T lymphocytes, Leu-19 (CD56) was also highly expressed on the hepatic TcR gamma delta cells. The possibility of hepatic TcR gamma delta cells being activated was further examined in mice. C3H/He mice injected with syngeneic tumor cells were demonstrated to have an increased number of liver MNC; such MNC showed an ability to proliferate in vitro. These mice eventually had a considerable proportion of TcR gamma delta cells in the liver, showing activation markers, the Ia and LFA-1 antigens. These results suggest that the liver may be an important organ for activation and probably expansion of TcR gamma delta cells especially in tumor bearing hosts.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 409
page 409
icon of scanned page 410
page 410
icon of scanned page 411
page 411
icon of scanned page 412
page 412
icon of scanned page 413
page 413
icon of scanned page 414
page 414
icon of scanned page 415
page 415
Version history
  • Version 1 (August 1, 1990): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts